心脏肿瘤学临床试验的多样性：JACC：心脏肿瘤学操作方法。
Diversity in Cardio-Oncology Clinical Trials: JACC: CardioOncology How To.
发表日期：2024 Jun
作者：
Yehoda M Martei, Henrietta A Afari, Carmen E Guerra
来源：
JACC: CardioOncology
摘要：
•心血管疾病和癌症方面健康不平等的交叉性可能会加剧心脏肿瘤学的不平等。•公平参与临床试验是减轻这些健康差异的众多关键策略之一。•心脏肿瘤学试验应收集并报告参与者的种族和民族，包括较小少数群体的分类数据。•成功的干预措施包括针对结构、临床、提供者和患者层面障碍的多层次策略。© 2024 作者。
•Intersectionality of health inequities in CVD and cancer may compound inequities in cardio-oncology.•Equitable access to clinical trials is 1 of many key strategies to mitigate these health disparities.•Cardio-oncology trials should collect and report the race and ethnicity of participants, including disaggregate data on smaller minority groups.•Successful interventions consist of multilevel strategies targeting structural-, clinical-, provider-, and patient-level barriers.© 2024 The Authors.